Generally, Ack1 involvement in cancer and other diseases occurs at one of three different levels: genomic (amplification and mutations), transcriptional (overexpression), and post-transcriptional (downregulation of tumor suppressors). This evidence concerns the gene TNK2 and neoplasm.